insights_auto
Why is 51S down 14,29%?
Dive Deeperchevron_right
51S:FRA
Cynata Therapeutics Ltd
âŽ0,0060
arrow_downward
-14,29%(-0,0010) 1D
12 āš.āšĨ., 22 āŧāšĄāš 0 āšāšēāšāšĩ 00 āš§āšīāšāšēāšāšĩ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 51S...
Open
âŽ0,01
High
âŽ0,01
Low
âŽ0,01
Mkt. cap
4,09Â āšĨāŧāšēāš
Avg. vol.
0,00
Volume
0,00
52-wk high
âŽ0,24
52-wk low
âŽ0,00
No. of employees
0
Open
âŽ0,01
High
âŽ0,01
Low
âŽ0,01
Mkt. cap
4,09Â āšĨāŧāšēāš
Avg. vol.
0,00
Volume
0,00
52-wk high
âŽ0,24
52-wk low
âŽ0,00
No. of employees
0
News stories
From web sources and news partners
TipRanks
·
15 āšāšŧāŧāš§āŧāšĄāšāšāŧāšāš
Cynata Sets Target Market for New Share Options in Revised Prospectus
TipRanks
·
16 āšāšŧāŧāš§āŧāšĄāšāšāŧāšāš
Cynata Launches Fully Underwritten Entitlement Offer via Replacement Prospectus
Kalkine
·
17 āšāšŧāŧāš§āŧāšĄāšāšāŧāšāš
Cynata Therapeutics Issues Replacement Prospectus for $913,000 Entitlement Offer at $0.01 Per Share
About Cynata Therapeutics Ltd